NIHON KAGAKU SANGYO CO.,LTD. [4094.T]
TOKYO, Apr 28 (Pulse News Wire) – Nihon Kagaku Sangyo CO.,LTD. (4094.T) announced today that its board of directors has decided on changes effective June 26, 2026.
Formal approval will follow at the scheduled annual shareholders' meeting on June 26, 2026. The key appointments include: - Akatani Hiromi, currently serving as President and Representative Director, will retain his position while also taking on additional responsibilities as Head of Pharmaceutical Business.
- Matsuo Ri, currently serving as Executive Vice President in charge of the Pharmaceutical Business Division, will be appointed as a new director and concurrently serve as Senior Managing Officer overseeing the Pharmaceutical Business Headquarters. These changes aim to strengthen leadership within the pharmaceutical sector of the company.
Further details will be available upon formal confirmation at the upcoming shareholders' meeting.
🟢 Confidence: High AI-translated content.